Full Text (PDF)
Original Article

Evaluation of Oral Labetalol Versus Methyldopa in Hypertensive Disorders Complicating Pregnancy

Gauri Dank** , Shubhangi Mande* , Gauri Dank** , Swati Shiradkar*** , Shruti Bhamre****

Author Information

Licence:




Indian Journal of Maternal-Fetal & Neonatal Medicine 3(2):p 87-92, July - December 2016. | DOI: DOI: http://dx.doi.org/10.21088/ijmfnm.2347.999X.3216.5

How Cite This Article:


Timeline

Received : N/A         Accepted : N/A          Published : N/A

Abstract

Aims & Objectives: To compare the efficacy and safety of labetalol versus methyldopa in the management of preeclampsia Materials & Method:s Eligible women were randomly assigned, treated with Tab. Labetalol and Tab Methyldopa alternatively with matching distribution, 85 patients in each group. Results: Labetalol is very effective and has early onset of control of blood pressure control with less side effects. No fetal adverse effects were seen. Conclusion: Labetalol is safe. Inspite of cost, labetalol is very effective and early onset of control of blood pressure is seen. In patients on Labetalol requirement of adding other antihypertensive is much less than methyldopa.With effective control of blood pressure, prevention of eclampsia and the pregnancy can be prolonged to achieve fetal maturity.Labetalol is not associated with adverse fetal effects. 

Keywords: Labetalol; Alpha Methyldopa; Preeclampsia.


References

No records found.


About this article


Cite this article


Licence:




Received Accepted Published
N/A N/A N/A

DOI: DOI: http://dx.doi.org/10.21088/ijmfnm.2347.999X.3216.5

Keywords


Article Level Metrics

Last Updated

Sunday 18 October 2026, 15:09:57 (IST)


1732

Accesses

6
189
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received N/A
Accepted N/A
Published N/A

licence



Access this article



Share